MAPT and Alzheimer disease: Alzheimer's disease (AD), a progressive neurodegenerative disorder, characterized by amyloid‐beta (Aβ) aggregation, tau hyperphosphorylation, oxidative stress, and neuroinflammation resulted the cognitive memory loss.